CALCOCO1 Antibody

What is CALCOCO1 and why is it of interest to researchers?

CALCOCO1 (calcium binding and coiled-coil domain 1) is a 691 amino acid protein that functions as a coactivator for aryl hydrocarbon and nuclear receptors. It shuttles between the cytoplasm and nucleus, playing significant roles in several cellular pathways. Recent research has identified CALCOCO1 as a component of the MTOR-regulated autophagy pathway, specifically in selective autophagy of the endoplasmic reticulum (reticulophagy) . The protein forms a calphoglin complex with PPA1 and PGM1, and contains multiple functional domains through which it acts in both androgen signaling and Wnt/beta-catenin signaling pathways . Its role in autophagy regulation makes it particularly relevant for cancer and metabolic disease research.

How does CALCOCO1 structurally relate to other autophagy receptor proteins?

CALCOCO1 is an evolutionary conserved protein and a paralog to TAX1BP1 and NDP52 (also known as CALCOCO2), which are established selective autophagy receptor proteins. All three proteins share substantial sequence similarity and a common domain architecture consisting of:

• An N-terminal SKIP carboxyl homology (SKICH) domain

• Middle coiled-coil regions (CC1-3)

• C-terminal domains containing zinc finger motifs

• An atypical LC3-interacting region (LIR) called CLIR (with an LVV motif) located in the linker region between the SKICH domain and coiled-coil domain

This structural similarity suggests functional relationships in autophagy pathways, though CALCOCO1 has distinct roles in reticulophagy that differentiate it from its paralogs.

What are the optimal storage conditions for CALCOCO1 antibodies to maintain reactivity?

For most CALCOCO1 antibodies, the recommended storage conditions are:

• Long-term storage: -20°C for most formulations, though some recombinant antibodies require -80°C storage

• Most CALCOCO1 antibodies are stable for one year after shipment when stored appropriately

• Antibodies in PBS with 0.02% sodium azide and 50% glycerol (pH 7.3) can be stored at -20°C, and aliquoting is generally unnecessary for this formulation

• Some preparations (particularly the 20μL sizes) contain 0.1% BSA, which helps maintain antibody stability

• Antibodies should be allowed to equilibrate to room temperature before opening to prevent condensation that could affect activity

Which applications are CALCOCO1 antibodies validated for, and what are the recommended dilutions?

CALCOCO1 antibodies have been validated for multiple applications with specific dilution recommendations:

It is important to note that optimal dilutions may be sample-dependent and should be determined empirically for each experimental system. Commercial antibodies have been tested with various cell lines and tissues, including HEK-293T, HT-1080, HeLa, MCF-7, Ramos, and NIH/3T3 cells for WB applications .

What methodological approaches are recommended for detecting CALCOCO1 in autophagy studies?

For autophagy studies involving CALCOCO1:

• Basal autophagy assessment: Monitor endogenous CALCOCO1 levels in normal growth conditions with and without bafilomycin A1 (Baf A1). CALCOCO1 accumulates with Baf A1 treatment, similar to the established autophagy receptor p62, indicating basal turnover by autophagy .

• Induced autophagy monitoring: For nutrient starvation experiments, CALCOCO1 levels decrease significantly after approximately 6 hours of starvation. This reduction can be blocked by Baf A1 treatment during starvation, confirming CALCOCO1 as an autophagy substrate .

• Co-localization studies: Immunofluorescence can be used to examine co-localization of CALCOCO1 with autophagy markers such as MAP1LC3/LC3 proteins, particularly MAP1LC3C with which CALCOCO1 physically interacts .

• Genetic manipulation approaches: CALCOCO1 knockout or knockdown studies are effective for investigating its functional role in reticulophagy. Comparison between wild-type and CALCOCO1-deficient cells during autophagy induction provides insights into its mechanistic contributions .

How can researchers optimize antigen retrieval for CALCOCO1 detection in IHC applications?

For optimal antigen retrieval in IHC applications using CALCOCO1 antibodies:

• Primary recommendation: Use TE buffer at pH 9.0 for antigen retrieval, which has been shown to provide optimal results with human and mouse tissues .

• Alternative approach: Citrate buffer at pH 6.0 can be used as an alternative method if the primary recommendation yields suboptimal results .

• Tissue-specific considerations: The antigen retrieval method has been validated for human testis and kidney tissues, as well as mouse brain and testis tissues. Different tissues may require optimization of retrieval conditions .

• Incubation parameters: After antigen retrieval, allow sections to cool gradually to room temperature before proceeding with blocking and primary antibody incubation steps.

• Signal amplification: For tissues with lower CALCOCO1 expression, consider using polymer-based detection systems that provide signal amplification without increasing background.

How should researchers address the discrepancy between calculated and observed molecular weights of CALCOCO1?

The calculated molecular weight of CALCOCO1 is 77 kDa (based on its 691 amino acid sequence), but it is consistently observed at approximately 100 kDa in Western blot analyses . This discrepancy should be addressed as follows:

• Expected band recognition: Researchers should be aware that the authentic CALCOCO1 band appears at ~100 kDa rather than at the calculated 77 kDa position.

• Post-translational modifications: The higher observed molecular weight likely reflects post-translational modifications. These modifications may include phosphorylation, which is common for signaling proteins and coactivators.

• Validation approaches:

  • Use positive controls from cells known to express CALCOCO1 (HEK-293T, HeLa, etc.)

  • Include knockdown/knockout controls to confirm band specificity

  • Consider using multiple antibodies targeting different epitopes of CALCOCO1

  • If studying novel tissues/cells, validate with both Western blot and another method (e.g., immunofluorescence)

• Denaturing conditions: Ensure complete protein denaturation with appropriate SDS concentration and heating, as incomplete denaturation of coiled-coil proteins can affect migration patterns.

What controls are essential when studying CALCOCO1 in autophagy-related experiments?

When investigating CALCOCO1's role in autophagy, the following controls are critical:

• Pharmacological controls:

  • Bafilomycin A1 (Baf A1) treatment: Essential for distinguishing between increased autophagy flux and blocked lysosomal degradation

  • MTOR inhibitors (e.g., MLN0128): Valuable for inducing autophagy through the canonical MTOR pathway

  • Chloroquine (CQ): Alternative lysosomal inhibitor that can be used to confirm Baf A1 results

• Genetic controls:

  • ATG5 or ULK1/ULK2 knockout cells: Important for distinguishing autophagy-dependent from autophagy-independent effects

  • CALCOCO1 knockout/knockdown cells: Essential for validating antibody specificity and determining CALCOCO1-dependent effects

  • Rescue experiments: Re-expression of wild-type CALCOCO1 in knockout cells to confirm specificity of observed phenotypes

• Interaction controls:

  • MAP1LC3C binding mutants: To distinguish between effects dependent on direct LC3 interaction versus other CALCOCO1 functions

  • Coiled-coil domain mutants: To assess the importance of CALCOCO1 self-association, which is mediated primarily by the CC3 region (amino acids 413-513)

How does CALCOCO1 self-association affect experimental design and interpretation?

CALCOCO1 has been demonstrated to form homomeric complexes through its coiled-coil domains, with the CC3 region (amino acids 413-513) playing a particularly important role in this self-association . This has several implications for experimental design:

• Fusion protein considerations: When designing CALCOCO1 fusion constructs, researchers should be aware that N-terminal or C-terminal tags may affect self-association properties. Validation of tagged protein functionality through complementation studies is recommended.

• Dominant-negative approaches: Truncated forms of CALCOCO1 containing the CC domain (particularly CC3) may act as dominant-negative inhibitors by associating with endogenous CALCOCO1 but lacking functional domains. This can be exploited experimentally but should be considered when interpreting overexpression phenotypes.

• Co-immunoprecipitation experiments: When performing co-IP to study CALCOCO1 interactors, stringent washing conditions may disrupt some interactions. Conversely, mild conditions may preserve indirect interactions mediated through CALCOCO1 self-association. Cross-validation with yeast two-hybrid or proximity labeling approaches is recommended.

• Microscopy considerations: In fluorescence microscopy studies, CALCOCO1 self-association may lead to the formation of visible puncta or aggregates, particularly when overexpressed. These structures should not be automatically interpreted as physiological without validation in endogenous contexts.

How does CALCOCO1 specifically contribute to reticulophagy compared to other selective autophagy receptors?

CALCOCO1 has been identified as a soluble receptor specifically involved in the degradation of tubular ER membranes through selective autophagy (reticulophagy) . Its distinct role compared to other autophagy receptors includes:

• Substrate specificity: CALCOCO1 shows specificity for tubular ER membranes rather than other cellular components targeted by traditional autophagy receptors like p62/SQSTM1 (protein aggregates) or NDP52/CALCOCO2 (intracellular pathogens) .

• Stress response patterns: CALCOCO1-mediated reticulophagy is particularly active during proteotoxic and nutrient stress conditions. Unlike general autophagy receptors, CALCOCO1 itself is subject to autophagic degradation during nutrient starvation, suggesting a regulatory feedback mechanism .

• Interaction partners: CALCOCO1 physically interacts with MAP1LC3C through its atypical LIR (CLIR) motif. This interaction appears more specific than the broader LC3/GABARAP interactions seen with some other autophagy receptors .

• Structural requirements: The distinct domain arrangement of CALCOCO1, particularly its coiled-coil regions and zinc finger domains, likely contributes to its specific function in recognizing and recruiting ER membranes to autophagosomes. Mutational analysis of these domains can help delineate their specific contributions.

• Methodological approaches to investigate these distinctions include:

  • Comparative proteomics of autophagosomes isolated from cells under different stress conditions

  • Domain-swapping experiments between CALCOCO1 and related receptors

  • Live-cell imaging with fluorescently tagged CALCOCO1 and ER markers during induced stress

What is the relationship between CALCOCO1's nuclear receptor coactivator function and its role in autophagy?

CALCOCO1 has dual functionality as both a nuclear receptor coactivator and an autophagy receptor, which raises important questions about potential cross-regulation between these pathways:

• Compartmentalization: CALCOCO1 shuttles between the nucleus and cytoplasm, suggesting that its localization may be regulated to balance its different functions. Researchers should consider:

  • Using subcellular fractionation combined with Western blotting to quantify nuclear versus cytoplasmic distribution under different conditions

  • Employing immunofluorescence with co-staining for nuclear envelope markers to visualize translocation

  • Creating nuclear localization signal (NLS) or nuclear export signal (NES) mutants to investigate compartment-specific functions

• Stress-induced transitions: During cellular stress, CALCOCO1 may shift from transcriptional coactivation to autophagy roles. This can be investigated by:

  • Chromatin immunoprecipitation (ChIP) assays before and after stress induction

  • Reporter gene assays to measure coactivator function during autophagy activation

  • Proteomics analysis of CALCOCO1 interactors in different cellular compartments and stress conditions

• Post-translational modifications: Different modifications may direct CALCOCO1 toward specific functions. Consider:

  • Phosphoproteomic analysis after various stimuli

  • Creating phosphomimetic or phospho-deficient mutants to determine effects on localization and function

  • Investigating kinases and phosphatases that may regulate CALCOCO1 activity

• Transcriptional regulation of autophagy: CALCOCO1 might influence the expression of autophagy genes through its coactivator function, creating a regulatory loop. This can be examined through:

  • Transcriptome analysis in CALCOCO1 knockout cells versus cells expressing nuclear-restricted CALCOCO1

  • ChIP-seq to identify genomic binding sites of CALCOCO1-containing complexes

  • Analysis of autophagy gene expression during CALCOCO1-dependent transcriptional activation

How can researchers differentiate between CALCOCO1's direct role in autophagy versus indirect effects through transcriptional regulation?

Distinguishing between direct and indirect effects of CALCOCO1 on autophagy requires careful experimental design:

• Rapid induction systems: Use of systems allowing rapid protein depletion or activation can help distinguish direct effects from transcriptional consequences:

  • Auxin-inducible degron (AID) system for rapid CALCOCO1 depletion

  • Optogenetic or chemical dimerization approaches for acute recruitment of CALCOCO1 to autophagic structures

• Domain-specific mutants: Create and compare CALCOCO1 mutants with selective disruption of either:

  • Transcriptional coactivator function (mutations in transactivation domains)

  • Autophagy-related functions (mutations in LC3-interacting region or cargo-binding domains)

• Transcription inhibition: Compare autophagy phenotypes with and without transcriptional inhibitors (e.g., actinomycin D) to separate immediate versus transcription-dependent effects.

• Temporal analysis: Detailed time-course experiments can reveal the sequence of events:

  • Early events (minutes to hours) more likely represent direct autophagy functions

  • Later events (hours to days) may involve transcriptional regulation

  • Combining protein and mRNA measurements at multiple time points helps establish causality

• Proximity labeling approaches: BioID or APEX2 fusions to CALCOCO1 can identify proteins in close proximity in different cellular compartments, helping assign compartment-specific functions.

What strategies can resolve non-specific binding issues when using CALCOCO1 antibodies?

When encountering non-specific binding with CALCOCO1 antibodies, consider these methodological approaches:

• Antibody selection and validation:

  • Prioritize antibodies validated with knockout/knockdown controls

  • Consider recombinant antibodies (like 84009-4-PBS) which may offer higher specificity than conventional polyclonal antibodies

  • Validate with multiple antibodies targeting different epitopes of CALCOCO1

• Blocking optimization:

  • Extend blocking time (1-2 hours at room temperature or overnight at 4°C)

  • Test alternative blocking agents (5% BSA, 5% non-fat dry milk, commercial blockers)

  • Include 0.1-0.3% Triton X-100 in blocking solution for membrane permeabilization

• Antibody dilution optimization:

  • For Western blot, start with higher dilutions (1:5000-1:10000) and adjust based on results

  • For IHC and IF, begin with mid-range dilutions (1:100 for IHC, 1:200 for IF) and optimize

• Washing procedures:

  • Increase number of washes (5-6 washes of 5-10 minutes each)

  • Add 0.1% Tween-20 to washing buffer to reduce non-specific interactions

  • Use larger volumes of wash buffer

• Protein extraction methods for Western blot:

  • Compare RIPA buffer versus gentler NP-40 or Triton X-100 based buffers

  • Include protease inhibitors to prevent degradation products that may appear as non-specific bands

  • Consider phosphatase inhibitors as CALCOCO1 may be phosphorylated

How can researchers resolve discrepancies in CALCOCO1 detection between different experimental techniques?

When facing inconsistent results between different detection methods for CALCOCO1:

• Epitope accessibility issues:

  • Different techniques (WB, IHC, IF) expose different epitopes

  • For fixed tissues/cells, compare different fixation methods (PFA, methanol, acetone)

  • Test multiple antibodies recognizing different regions of CALCOCO1

• Expression level considerations:

  • CALCOCO1 may be expressed at low levels in some tissues, requiring signal amplification

  • For IHC, consider tyramide signal amplification (TSA) systems

  • For WB, longer exposure times or more sensitive detection reagents may be needed

• Cross-validation approaches:

  • Confirm protein expression with mRNA analysis (RT-qPCR or RNA-seq)

  • Use tagged CALCOCO1 constructs (GFP, FLAG, etc.) in parallel with antibody detection

  • Employ mass spectrometry-based proteomics as an antibody-independent validation

• Sample preparation consistency:

  • Standardize lysis conditions and buffer compositions

  • Control for post-translational modifications using phosphatase treatment

  • Consider native versus denaturing conditions for different applications

• Positive and negative controls:

  • Include tissues/cells known to express high levels of CALCOCO1 (e.g., testis tissue)

  • Use CALCOCO1 knockout or knockdown samples as negative controls

  • For overexpression systems, include both empty vector and CALCOCO1 overexpression controls

What methodological approaches help overcome detection challenges in tissue samples with low CALCOCO1 expression?

For detecting CALCOCO1 in tissues with low expression levels:

• Sample enrichment techniques:

  • Immunoprecipitation before Western blotting to concentrate CALCOCO1

  • Subcellular fractionation to isolate nuclear or cytoplasmic fractions where CALCOCO1 may be enriched

  • For protein lysates, use higher total protein amounts (50-100 μg)

• Signal amplification methods:

  • For IHC: Use polymer-based detection systems or tyramide signal amplification

  • For IF: Employ secondary antibody amplification systems (e.g., biotinylated secondary + streptavidin-fluorophore)

  • For WB: Use enhanced chemiluminescence (ECL) substrates designed for femtogram-level detection

• Autophagic flux manipulation:

  • Treat samples with bafilomycin A1 to prevent CALCOCO1 degradation and increase detection sensitivity

  • Consider stress conditions that may upregulate CALCOCO1 (e.g., ER stress inducers)

• Alternative detection methods:

  • Proximity ligation assay (PLA) to detect CALCOCO1 interactions with known binding partners

  • RNAscope or other in situ hybridization techniques to detect CALCOCO1 mRNA as a complement to protein detection

  • Mass spectrometry-based targeted proteomics using selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

• Tissue processing optimization:

  • Compare fresh frozen versus formalin-fixed paraffin-embedded (FFPE) samples

  • Optimize antigen retrieval methods specifically for tissues of interest

  • Consider shorter fixation times to improve epitope accessibility